Author

V. Petrosius

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

E. M. Schoof· 2 shared B. Furtwängler· 1 shared B. T. Porse· 1 shared B. W. Kristensen· 1 shared C. S. Sorensen· 1 shared C. V. Rift· 1 shared D. Bulanova· 1 shared E. S. Rugiu· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

E. M. Schoof

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Refining Spatial Proteomics by Mass Spectrometry: An Efficient Workflow Tailored for Archival Tissue

R. Daucke, C. V. Rift, N. S. Bager, K. Saxena, P. R. Koffeldt, J. Woessmann, V. Petrosius, E. S. Rugiu, B. W. Kristensen, P. Klausen, E. M. Schoof

This paper develops an efficient workflow for spatial proteomics on FFPE tissue using low-input material, showing that EpCAM staining improves protein identification compared to H&E staining.

BMC Methods · Apr 22, 2026Peer-reviewedBioengineering

Unraveling the proteome landscape of mouse hematopoietic stem and progenitor compartment with high sensitivity low-input proteomics

N. Üresin, V. Petrosius, P. A. Fernandez, B. Furtwängler, E. M. Schoof, B. T. Porse

This study develops a low-input proteomics workflow to analyze rare hematopoietic stem and progenitor cells, identifying 7,000 proteins and a novel marker for long-term hematopoietic stem cells.

bioRxiv · May 3, 2024 · PreprintCell Biology

Synthetic lethal interaction between WEE1 and PKMYT1 is a target for multiple low dose treatment of high-grade serous ovarian carcinoma

J. Benada, D. Bulanova, V. Azzoni, V. Petrosius, S. Ghazanfar, K. Wennerberg, C. S. Sorensen

This study shows that combining low-dose WEE1 and PKMYT1 inhibition synergistically kills ovarian cancer cells by increasing genomic instability and inflammation, and is well-tolerated in mice.

bioRxiv · Mar 31, 2023Cancer Biology